Effects of α-synuclein overexpression in transgenic Caenorhabditis elegans strains

CNS and Neurological Disorders - Drug Targets

Volumn 11, Issue 8, 2012, Pages 965-975

  Bodhicharla, Rakesh ^a   Nagarajan, Archana ^a   Winter, Jody ^a   Adenle, Ademola ^b   Nazir, Aamir ^c   Brady, Declan ^a   Vere, Kelly ^a   Richens, Jo ^a   O'Shea, Paul ^a   Bell, David R ^d   de Pomerai, David ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNITED NATIONS UNIVERSITY   (Japan)

^c CENTRAL DRUG RESEARCH INSTITUTE   (India)

^d EUROPEAN CHEMICALS AGENCY   (Finland)

Author keywords

synuclein; Caenorhabditis elegans; CFP and YFP reporters; FRET; Protein aggregation; Transgenic strains

Indexed keywords

ALPHA SYNUCLEIN; FLUORESCENT DYE; HYBRID PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BROOD PARASITE; CAENORHABDITIS ELEGANS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEVELOPMENTAL STAGE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE OVEREXPRESSION; LIFESPAN; LOCOMOTION; MOLECULAR CLONING; MORPHOGENESIS; NONHUMAN; PHARYNX DISEASE; PROTEIN AGGREGATION;

ALPHA-SYNUCLEIN; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CAENORHABDITIS ELEGANS; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HUMANS; LONGEVITY; LUMINESCENT PROTEINS; MOVEMENT; SURVIVAL ANALYSIS;

EID: 84875009239     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527311211080005     Document Type: Article

References (35)

1. Dobson, C.M. Protein folding and misfolding. Nature, 2003, 426, 884-890.
2. Ross, C.A.; Poirier, M.A. What is the role of protein aggregation in neurodegeneration? Nature Rev. Molec. Biol., 2005, 6, 891-898.
3. Eliezer, D. Visualising amyloid assembly. Science, 2012, 336, 308-309.
4. Uversky, V. Neuropathology, biochemistry and biophysics of α-synuclein aggregation. J. Neurochem., 2007, 103, 17-37.
5. Spillantini, M.G.; Schmidt, M.L.; Lee, V.M.Y.; Trojanowski, J.Q.; Jakes, R.; Goedert, M. Alpha-synuclein in Lewy bodies. Nature, 1997, 388, 839-840.
6. Kruger, R.; Kuhn, W.; Muller, T.; Woitalla, D.; Graeber, M.; Kosel, S.; Przuntek, H.; Epplen, J.T.; Schols, L.; Riess, O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet., 1998, 18, 106-108.
7. Polymeropoulos, M.; Lavedan, C.; Leroy, E.; Ide, S.; Dehejia, A.; Dutra, A.; Pike, B.; Root, H.; Rubenstein, J.; Boyer, R.; Stenroos, E.S.; Chandrasekarappa, S.; Athanassiadou, A.; Papapetropoulos, T.; Johnson, W.G.; Lazzarini, A.M.; Duvoisin, R.C.; DiIorio, G.; Golbe, C.J.; Nussbaum, R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science, 1997, 276, 2045-2047.
8. Beal, M.F. Parkinson's disease: a model dilemma. Nature, 2010, 466, S8-S10.
9. Feany, M.B.; Bender, W.W. A Drosophila model for Parkinson's disease. Nature, 2000, 404, 394-398.
10. Ziviani, E.; Tao, R.N.; Whitworth, A.J. Drosophila Parkin requires PINK1 for mitochondrial translocation and ubiquitinates Mitofusin. Proc. Natl. Acad. Sci. USA, 2010, 107, 5018-5023.
11. Hamamichi, S.; Rivas, R.; Knight, A.; Cao, S.; Caldwell, K.; Caldwell, G. Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model. Proc. Natl. Acad. Sci. USA, 2008, 105, 728-733.
12. van Ham, T.; Thijssen, K.; Breitling, B.; Hofstra, R.; Plasterk, R.; Nollen, E.A. C. elegans model identifies genetic modifiers of α-synuclein inclusion formation during aging. PLoS Genet., 2008, 4, e100027.
13. Lakso, M.; Vartiainen, S.; Moilanen, A.-M.; Sirvio, J.; Thomas, J.; Nass, R.; Blakely, R.D.; Wong, G. Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human α-synuclein. J. Neurochem., 2002, 86, 165-172.
14. Leung, M.; Williams, P.; Benedetto, A.; Au, C.; Helmcke, K.; Ashner, M.; Meyer, J. Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology. Toxicol. Sci., 2008, 106, 5-28.
15. Brenner, S. Genetics of Caenorhabditis elegans. Genetics, 1974, 77, 71-94.
16. Fire, A. Integrative transformation of Caenorhabditis elegans. EMBO J., 1986, 5, 2673-2680.
17. Mello, C.C.; Kramer, J.M.; Stinchcomb, D.; Ambros, V. Efficient gene transfer in C. elegans: extrachromosomal maintenance and integration of transforming sequences. EMBO J., 1991, 10, 3959-3970.
18. C. elegans Sequencing Consortium. Genome sequence of the nematode C. elegans: a platform for investigating biology. Science, 1998, 282, 2012-2018.
19. Kamath, R.S.; Fraser, A.; Dong, Y.; Poulin, G.; Durbin, R.; Gotta, M.; Kanapin, A.; Le Bot, N.; Moreno, S.; Sohrmann, M.; Welchman, D.P.; Zipperlen, P.; Ahringer, J. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature, 2003, 421, 231-237.
20. Anbalagan, C.; Lafayette, I.; Antoniou-Kourounioti, M.; Haque, M.; King, J.; Gutierrez, G.; Rodriguez Martin, J.; de Pomerai, D. Transgenic nematodes as biosensors for metal stress in soil water samples. Ecotoxicology, 2012, 21, 439-455.
21. van Ham, J.; Esposito, A.; Kumita, J.; Hsu, S.T.; Kaminski Schierle, G.; Kaminski, C.; Dobson, C.; Nollen, E.; Bertoncini, C. Towards multiparametric fluorescent imaging of amyloid formation: studies of a YFP model of α-synuclein aggregation. J. Molec. Biol., 2010, 395, 627-642.
22. Miyawaki, A.; Tsien, R.Y. Monitoring protein conformations and interactions by fluorescence resonance energy transfer between mutants of Green Fluorescent protein. Appl. Chim. Genes Hybrid Prot. (Part B), 2000, 327, 472-500.
23. Rekas, A.; Adda, C.G.; Aquilina, J.A.; Barnham, K.J.; Sunde, M.; Galatis, D.; Williamson, N.A.; Masters, C.L.; Anders, R.F.; Robinson, C.V.; Cappai, R.; Carver, J.A. Interaction of the molecular chaperone alpha B-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity. J. Molec. Biol., 2004, 340, 1167-1183.
24. Rizzo, M.A.; Springer, G.H.; Granada, B.; Piston, D.W. An improved cyan fluorescent protein variant useful for FRET. Nat. Biotechnol., 2004, 22, 445-449.
25. Nagai, T.; Ibata, K.; Park, E.S.; Kubota, M.; Mikoshiba, K.; Miyawaki, A. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol., 2002, 20, 87-90.
26. Boulin, T.; Etchberger, J.F.; Hobert, O. Reporter gene fusions. Wormbook (ed. The C. elegans research community), 2006, Wormbook doi/10.1895/wormbook.1.106.1, http://www.wormbook.org
27. Dennis, J.L.; Mutwakil, M.H.A.Z.; Lowe, K.C.; de Pomerai, D.I. Effects of metal ions in combination with a non-ionic surfactant on stress responses in a transgenic nematode. Aquat. Toxicol., 1997, 40, 37-50.
28. Williams, P.L.; Dusenbery, D.B. Aquatic toxicity testing using the nematode Caenorhabditis elegans. Environ. Toxicol. Chem., 1990, 9, 1285-1290.
29. Mutwakil, M.H.A.Z.; Steele, T.J.G.; Lowe, K.C.; de Pomerai, D.I. Surfactant stimulation of growth in the nematode Caenorhabditis elegans. Enzyme Microbiol. Technol., 1997, 20, 462-470.
30. Mitchell, D.H.; Stiles, J.W.; Santelli, J.; Sanadi, D.R. Synchronous growth and aging of Caenorhabditis elegans in the presence of fluorodeoxyuridine. J. Gerontol., 1979, 34, 28-36.
31. Hirsh, D.; Oppenheim, D.; Hass, M. Development of reproductive system of Caenorhabditis elegans. Develop. Biol., 1976, 49, 200-219.
32. Pincus, Z.; Smith-Vikos, T.; Slack, F.J. MicroRNA predictors of longevity in Caenorhabditis elegans. PLoS Genet., 2011, 7, e1002306.
33. Roodveldt, C.; Bertoncini, C.; Andersson, A.; van der Goot, A.; Hsu, S.-T.; Fernandez-Montesinos, R.; de Jong, J.; van Ham, T.J.; Nollen, E.A.; Pozo, D.; Christodoulou, J.; Dobson, C.M. Chaperone proteostasis in Parkinson's disease: stabilisation of the Hsp70/α-synuclein complex by Hip. EMBO J., 2009, 28, 3758-3770.
34. David, D.C.; Ollikainen, N.; Trinidad, J.C.; Cary, M.P.; Burlingame, A.L.; Kenyon, C. Widespread protein aggregation as an inherent part of aging in C. elegans. PLoS Biol., 2010, 8, e1000450.
35. Vartiainen, S.; Aarnio, V.; Lakso, M.; Wong, G. Increased lifespan in transgenic Caenorhabditis elegans overexpressing human α-synuclein. Exper. Gerontol., 2006, 41, 871-876.